Profund Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,221
| Closed | -$108K | – | 995 |
|
|
2025
Q1 | $108K | Sell |
10,221
-865
| -8% | -$9.16K | ﹤0.01% | 946 |
|
|
2024
Q4 | $188K | Sell |
11,086
-1,728
| -13% | -$29.3K | 0.01% | 1021 |
|
|
2024
Q3 | $297K | Sell |
12,814
-1,495
| -10% | -$34.7K | 0.01% | 802 |
|
|
2024
Q2 | $348K | Sell |
14,309
-9,915
| -41% | -$241K | 0.01% | 634 |
|
|
2024
Q1 | $818K | Buy |
24,224
+5,800
| +31% | +$196K | 0.03% | 408 |
|
|
2023
Q4 | $581K | Sell |
18,424
-3,874
| -17% | -$122K | 0.03% | 472 |
|
|
2023
Q3 | $570K | Sell |
22,298
-6,310
| -22% | -$161K | 0.03% | 430 |
|
|
2023
Q2 | $820K | Sell |
28,608
-887
| -3% | -$25.4K | 0.04% | 368 |
|
|
2023
Q1 | $707K | Buy |
+29,495
| New | +$707K | 0.04% | 397 |
|